Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 10.75
0.186 %
$ 979 M
Market Cap
-7.62
P/E
MYGN - COST OF REVENUE
Cost of Revenue MYGN - Myriad Genetics, Inc.
236 M
LAST VALUE
9.33%
2 YEAR CAGR
3.28%
5 YEAR CAGR
8.02%
10 YEAR CAGR